Comparative genomics in the fight against tuberculosis: diagnostics, epidemiology, and BCG vaccination.
Although the causative agent of tuberculosis, Mycobacterium tuberculosis, has been known for some 120 years, the disease continues to plague humanity. In 1998, the sequencing of M. tuberculosis H37Rv enabled tuberculosis researchers to draw comparisons between it and other species of the closely-related M. tuberculosis complex, including bacillus Calmette-Guerin (BCG), the vaccine administered to prevent human tuberculosis. These efforts have uncovered genomic variability that potentially encodes the discrepant phenotypes displayed by species. Due to the infrequency of single nucleotide polymorphisms (SNPs) and other modes of genomic change, large sequence polymorphisms (LSPs) have presented themselves as the most obvious form of genomic variability among species. This review discusses genomic polymorphism among species of the M. tuberculosis complex as revealed through comparative genomics. Attention is drawn towards the impact of comparative genomics in generating several exciting hypotheses towards diagnosis, epidemiology, and prevention of tuberculosis disease.
Mostowy
Serge
S
Division of Infectious Diseases and Medical Microbiology, McGill University Health Centre, Montreal, Quebec, Canada.
Behr
Marcel A
MA
D001500:BCG Vaccine / Q000627:therapeutic use*; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods / Q000706:statistics & numerical data; D014376:Tuberculosis / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics / Q000517:prevention & control*
D001500:BCG Vaccine